Read + Share
Amedeo Smart
Independent Medical Education
Perez de Llano LA, Cosio BG, Lobato Astiarraga I, Soto Campos G, et al. First line versus second line use of reslizumab in severe uncontrolled asthma. J Investig Allergol Clin Immunol 2022 Jun 27:0. doi: 10.18176/jiaci.0839.PMID: 35797112
Email
LinkedIn
Facebook
Twitter
Privacy Policy